Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 AUD | +4.00% | +4.00% | -7.14% |
02-29 | Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
01-11 | Compumedics Expects to Hit Record Fiscal H1 Revenue | MT |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 97.44 | 108.1 | 73.52 | 69.98 | 27.46 | 31.89 |
Enterprise Value (EV) 1 | 95.42 | 105.1 | 71.91 | 69.03 | 26.71 | 37.56 |
P/E ratio | 35 x | 26.9 x | -12.6 x | 70.1 x | 20.2 x | -5.14 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.63 x | 2.6 x | 2.1 x | 1.96 x | 0.73 x | 0.74 x |
EV / Revenue | 2.58 x | 2.53 x | 2.05 x | 1.93 x | 0.71 x | 0.88 x |
EV / EBITDA | 24.1 x | 18.5 x | 270 x | 46.7 x | 17.8 x | -14.5 x |
EV / FCF | -33.3 x | -96.2 x | -1,937 x | -116 x | -19 x | -11.6 x |
FCF Yield | -3% | -1.04% | -0.05% | -0.86% | -5.26% | -8.65% |
Price to Book | 4.21 x | 3.96 x | 3.37 x | 3.16 x | 1.16 x | 1.74 x |
Nbr of stocks (in thousands) | 177,163 | 177,163 | 177,163 | 177,163 | 177,163 | 177,163 |
Reference price 2 | 0.5500 | 0.6100 | 0.4150 | 0.3950 | 0.1550 | 0.1800 |
Announcement Date | 24/09/18 | 30/09/19 | 30/09/20 | 29/09/21 | 30/09/22 | 28/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 37 | 41.5 | 35.07 | 35.74 | 37.76 | 42.92 |
EBITDA 1 | 3.956 | 5.679 | 0.266 | 1.478 | 1.5 | -2.598 |
EBIT 1 | 3.694 | 5.348 | -0.329 | 0.957 | 0.987 | -3.019 |
Operating Margin | 9.98% | 12.89% | -0.94% | 2.68% | 2.61% | -7.03% |
Earnings before Tax (EBT) 1 | 3.487 | 5.087 | -7.503 | 0.776 | 1.698 | -6.719 |
Net income 1 | 2.784 | 4.016 | -5.838 | 0.998 | 1.357 | -6.122 |
Net margin | 7.52% | 9.68% | -16.65% | 2.79% | 3.59% | -14.26% |
EPS 2 | 0.0157 | 0.0227 | -0.0330 | 0.005633 | 0.007659 | -0.0350 |
Free Cash Flow 1 | -2.867 | -1.092 | -0.0371 | -0.5951 | -1.406 | -3.247 |
FCF margin | -7.75% | -2.63% | -0.11% | -1.67% | -3.72% | -7.57% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 24/09/18 | 30/09/19 | 30/09/20 | 29/09/21 | 30/09/22 | 28/09/23 |
Balance Sheet Analysis
Fiscal Period: Juni | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 5.67 |
Net Cash position 1 | 2.02 | 3.01 | 1.61 | 0.95 | 0.75 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | -2.182 x |
Free Cash Flow 1 | -2.87 | -1.09 | -0.04 | -0.6 | -1.41 | -3.25 |
ROE (net income / shareholders' equity) | 12.9% | 15.9% | -23.8% | 4.54% | 5.93% | -29.2% |
ROA (Net income/ Total Assets) | 7.23% | 9.12% | -0.55% | 1.61% | 1.54% | -4.55% |
Assets 1 | 38.52 | 44.04 | 1,053 | 61.8 | 88.28 | 134.5 |
Book Value Per Share 2 | 0.1300 | 0.1500 | 0.1200 | 0.1300 | 0.1300 | 0.1000 |
Cash Flow per Share 2 | 0.0200 | 0.0300 | 0.0400 | 0.0400 | 0.0400 | 0.0200 |
Capex 1 | 0.21 | 1.31 | 0.4 | 0.16 | 0.62 | 0.92 |
Capex / Sales | 0.56% | 3.17% | 1.15% | 0.46% | 1.63% | 2.15% |
Announcement Date | 24/09/18 | 30/09/19 | 30/09/20 | 29/09/21 | 30/09/22 | 28/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.14% | 30.46M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- CMP Stock
- Financials Compumedics Limited